Single-centre Study to Investigate Safety and Efficacy of Tri-Solfen in Wound Debridement

NCT03865147 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Wounds Injuries
Anesthesia, Local

Interventions

DRUG: Tri-Solfen Gel (Lidocaine HCl, Bupivacaine HCl, Adrenaline Acid Tartrate /Cetrimide)
DRUG: EMLA cream
DRUG: Post Operative Analgesia (Paracetamol, Ibuprofen)

Sponsor

Medical Ethics UK Ltd

Collaborators

[object Object]
[object Object]